PDL Biopharma Sues to Protect Cardene I.V.

Law360, New York (April 18, 2007, 12:00 AM EDT) -- An Indian pharmaceutical company has been hit with a patent infringement suit over its efforts to move in on the market for PDL Biopharma Inc.’s hypertension treatment Cardene I.V.

PDL Biopharma filed a lawsuit Tuesday in the U.S. District Court for the Eastern District of Michigan against Sun Pharmaceutical Industries Ltd., which is identified in the complaint as a subsidiary of Mumbai-based “Sun India.”

Also on Tuesday, PDL Biopharma filed a suit looking to enforce the same patent against the same defendant in the U.S. District...
To view the full article, register now.